[G19-06] Trametinib (melanoma) - Addendum to Commission A18-60
Last updated 22.03.2019
Project no.: G19-06
Commission: Commission awarded on 11.03.2019 by the Federal Joint Committee (G-BA).
Report type: Addendum
Status: Commission completed
Department/Division: Health Economics
Topic: Cancer
Note:
If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.
Federal Joint Committee (G-BA)
2019-03-22 A G-BA decision was published.